Indications And Dose
Reduction in duration of neutropenia and incidence of febrile neutropenia in cytotoxic chemotherapy for malignancy (except chronic myeloid leukaemia and myelodysplastic syndromes) ▶BY SUBCUTANEOUS INJECTION ▶Adult (specialist use only): 6 mg, for each chemotherapy cycle, given approximately 24 hours after chemotherapy, dose expressed as filgrastim
PDF page 1112

